CDC/ATSDR Peer Review Agenda
This site provides information on the independent peer review of documents defined by CDC as influential in terms of their potential impact on public policy or the private sector. CDC makes this information available to demonstrate its efforts to utilize only the most transparent and independent peer review, appropriate research methods, and the highest level of data quality. In addition, this information demonstrates CDC compliance with the specific requirements of the Information Quality Act (2000), 44 U.S.C. §3516, and of peer review standards developed by the Office of Management and Budget (OMB), Department of Health and Human Services (DHHS), and Centers for Disease Control and Prevention (CDC). OMB requirements, described in the Peer Review Bulletin, include making publicly available specific information on the peer review of influential documents disseminated by the federal government. OMB has defined two special categories of influential information, Influential Scientific Information (ISI) and Highly Influential Scientific Assessments (HISAs).
For issues related to the CDC/ATSDR Peer Review Agenda please contact:
Information Quality Peer Review Staff
Centers for Disease Control and Prevention
Office of Science Quality
1600 Clifton Road, NE MS D-72
Atlanta, GA 30333
The following HISAs and ISI are under development or published in final form:
Highly Influential Scientific Assessments (HISA)
- NIOSH Criteria for a Recommended Standard: 1-Bromopropane
- NIOSH Criteria for a Recommended Standard: Occupational Exposures to Diacetyl and 2, 3-pentanedione
- NIOSH Criteria for a Recommended Standard: Occupational Exposure to Hexavalent Chromium
- NIOSH Current Intelligence Bulletin: Health Effects of Occupational Exposure to Silver Nanomaterials
- NIOSH Current Intelligence Bulletin: Update of NIOSH Carcinogen Classification and Target Risk Level Policy for Chemical Hazards in the Workplace
- NIOSH Occupational Exposure Banding Process: Guidance for the Evaluation of Chemical Hazards
- NIOSH Skin Notation Profile for 1-Bromopropane (CAS# 106-94-5)
- NIOSH Skin Notation Profile for 2-Hydropropyl acrylate (CAS# 999-61-1)
- NIOSH Skin Notation Profile for Acrylic acid (CAS# 79-10-7)
- NIOSH Skin Notation Profile for Arsenic (CAS# 7440-38-2)
- NIOSH Skin Notation Profile for Atrazine (CAS# 1912-24-9)
- NIOSH Skin Notation Profile for Catechol (CAS# 120-80-9)
- NIOSH Skin Notation Profile for Chlorinated camphene (CAS# 8001-35-2)
- NIOSH Skin Notation Profile for Dichlorvos (CAS# 62-73-7)
- NIOSH Skin Notation Profile for Dimethyl sulfate (CAS# 77-78-1)
- NIOSH Skin Notation Profile for Dioxathion (CAS#78-34-2)
- NIOSH Skin Notation Profile for Disulfoton (CAS# 298-04-4)
- NIOSH Skin Notation Profile for Ethyl p-nitrophenyl phenylphosphorothioate (CAS# 2104-64-5)
- NIOSH Skin Notation Profile for Heptachlor (CAS# 76-44-8)
- NIOSH Skin Notation Profile for Morpholine (CAS# 110-91-8)
- NIOSH Skin Notation Profile for Pentachlorophenol (CAS# 87-86-5)
- NIOSH Skin Notation Profile for Sodium fluoroacetate (CAS# 62-74-8)
- NIOSH Skin Notation Profile for Tetraethyl lead (CAS# 78-00-2)
- NIOSH Skin Notation Profile for Tetramethyl lead (CAS# 75-74-1)
- NIOSH Skin Notation Profile for Trichloroethylene (CAS# 79-01-06)
- NIOSH IDLH Value Profile for 1,3-Butadiene (CAS 106-99-0)
- NIOSH IDLH Value Profile for Acetonitrile (CAS 75-05-8)
- NIOSH IDLH Value Profile for Acrylonitrile (CAS 107-13-1)
- NIOSH IDLH Value Profile for Benzonitrile (CAS 100-47-0)
- NIOSH IDLH Value Profile for Bromine pentafluoride (CAS 7789-30-2)
- NIOSH IDLH Value Profile for Butane (CAS 106-97-8)
- NIOSH IDLH Value Profile for Chlorine pentafluoride (CAS 13637-63-3)
- NIOSH IDLH Value Profile for Chloroacetonitrile (CAS 107-14-2)
- NIOSH IDLH Value Profile for Chloroacetyl chloride (CAS 79-04-9)
- NIOSH IDLH Value Profile for Diketene (CAS 674-82-8)
- NIOSH IDLH Value Profile for Furan (CAS 110-00-9)
- NIOSH IDLH Value Profile for HCFC-141B (1,1-Dichloro-1-Fluroethane)(CAS 1717-00-6)
- NIOSH IDLH Value Profile for Hexafluoroacetone (CAS 684-16-2)
- NIOSH IDLH Value Profile for Iron pentacarbonyl (CAS 13463-40-6)
- NIOSH IDLH Value Profile for Methacrylonitrile (CAS 126-98-7)
- NIOSH IDLH Value Profile for Methyl isocyanate (CAS 624-83-9)
- NIOSH IDLH Value Profile for n-Butyl acrylate (CAS 141-32-2)
- NIOSH IDLH Value Profile for Nitrogen Dioxide (CAS 10102-44-0)
Influential Scientific Information (ISI)
- A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs
- ATSDR Assessment of the Evidence for the Drinking Water Contaminants at Camp Lejeune and Specific Cancers and Other Diseases
- Best Practices for Cardiovascular Disease Prevention Programs: A Guide to Effective Health Care System Interventions and Community Programs Linked to Clinical Services
- Characterization of Departures from Regulatory Requirements Identified During Inspections Conducted by the US Federal Select Agent Program, 2014-15
- Draft NIOSH Practices in Occupational Risk Assessment
- Draft Skin Notation Profile: beta-Chloroprene
- Draft Skin Notation Profile: Chlorodiphenyl (42% chlorine)
- Draft Skin Notation Profile: Chlorodiphenyl (54% chlorine)
- Draft Skin Notation Profile: Cyclohexanol
- Draft Skin Notation Profile: Cyclohexanone
- Draft Skin Notation Profile: Cyclonite
- Draft Skin Notation Profile: Diacetyl and 2,3-Pentanedione
- Draft Skin Notation Profile: Diethylenetriamine
- Draft Skin Notation Profile: Dioxane
- Draft Skin Notation Profile: 2,4- and 2,6-Toluene diisocyanate
- Guidelines for the use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infection prevention
- Laboratory Recommendations for Syphilis Testing in the United States
- Interaction Profile on Metallic Ions In Fracturing Waste
- Multiple sclerosis technical report peer review plan
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2016
- NIOSH List of Hazardous Drugs in Healthcare Settings 2019 (formerly titled NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2018)
- Update on 3HP TB Peer Review Plan
- Official American Thoracic Society / Centers for Disease Control / Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- Parkinson’s disease technical report peer review plan
- Pediatric Mild Traumatic Brain Injury Guideline Report 2017
- Pediatric Mild Traumatic Brain Injury Guideline Report 2016
- Peer Review Plan for CDC Opioid Prescribing Guidelines for Chronic Pain
- Peer Review Plan For Recommendations for Hepatitis C Screening among Adults
- Peer Review Plan for Updated Recommendations for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States – 2016
- Recommendations for Hepatitis B Screening and Testing
- Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children – United States, 2023
- Reproductive Risks Associated with Hazardous Drugs in Healthcare and Recommendations for Reducing Exposures
- Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
- Sexually Transmitted Diseases Treatment Guidelines, 2014
- Sexually Transmitted Infections Treatment Guidelines, 2021 (cdc.gov)
- STI Treatment Guidelines (cdc.gov)
- Toxicological Profile for 1,1-Dichloroethane
- Toxicological Profile for 1,4-Dioxane
- Toxicological Profile for 1-Bromopropane
- Toxicological Profile for 1,2-Dichloropropane
- Toxicological Profile for 1,2-Diphenylhydrazine
- Toxicological Profile for 2,4-Dichlorophenoxyacetic Acid
- Toxicological Profile for Acrylamide
- Toxicological Profile for Antimony
- Toxicological Profile on Bromodichloromethane
- Toxicological Profile for Bromomethane
- Toxicological Profile for Butadiene
- Toxicological Profile for 2-Butanone
- Toxicological Profile for Chlorine
- Toxicological Profile for DEET (N,N-Diethyl-meta-toluamide)
- Toxicological Profile for Dinitrophenols
- Toxicological Profile for Dinitrotoluenes
- Toxicological Profile for Endosulfan
- Toxicological Profile for Ethyl Benzene
- Toxicological Profile for Ethylene Glycol
- Toxicological Profile for Glutaraldehyde
- Toxicological Profile for Glyphosate
- Toxicological Profile for Hexachlorobenzene
- Toxicological Profile for Hydrogen Sulfide and Carbonyl Sulfide
- Toxicological Profile for Jet fuels
- Toxicological Profile for Molybdenum
- Toxicological Profile for Nitrate and Nitrite
- Toxicological Profile for N-nitrosodi-n-propylamine
- Toxicological Profile for Parathion
- Toxicological Profile for Perfluoroalkyls
- Toxicological Profile for Perfluoroalkyls
- Toxicological Profile for Phosphate esters
- Toxicological Profile for RDX
- Toxicological Profile for Silica
- Toxicological Profile for Styrene
- Toxicological Profile for Tetrachloroethylene (PERC)
- Toxicological Profile for Toluene
- Toxicological Profile for Toluene Diisocyanate
- Toxicological Profile for Toxaphene
- Toxicological Profile for Trichlorobenzenes
- Toxicological Profile for Trichloroethylene (TCE)
- Toxicological Profile for 1,2,3-Trichloropropane
- Toxicological Profile for Uranium
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
- U.S. Selected Practice Recommendations for Contraceptive Use, 2016
- Updated Recommendations for Human Immunodeficiency Virus (HIV) Testing of Gay, Bisexual and Other Men who have Sex with men (MSM) in Health-Care Settings